Neurones - Public Comps and Valuation Multiples

Neurones Overview

About Neurones

Neurones SA is a France-based technology sector company. Its core business involves the provision of Information Technology (IT) services catering to the needs of hardware, software, and consulting. Its operations are thereby divided into three segments: Infrastructure Services, Application Services, and Consulting. The Infrastructure segment is the strongest revenue driver through the provision of such services as IT operations, IT service management, systems and network, server, application, and workstation outsourcing. Its second most profitable business is carried out through the Application segment, which entails SAP, Web and decision support, social media, data analysis.

Founded

1984

HQ

Employees

6.4K+

Website

neurones.net

Sectors

IT Consulting
Service Providers

Financials

LTM Revenue $887M

LTM EBITDA $106M

EV

$935M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Neurones Financials

Neurones has a last 12-month revenue of $887M and a last 12-month EBITDA of $106M.

In the most recent fiscal year, Neurones achieved revenue of $796M and an EBITDA of $106M.

Neurones expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Neurones valuation multiples based on analyst estimates

Neurones P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$715M	$796M	XXX	XXX	XXX
Gross Profit	$374M	$440M	XXX	XXX	XXX
Gross Margin	52%	55%	XXX	XXX	XXX
EBITDA	$97.9M	$106M	XXX	XXX	XXX
EBITDA Margin	14%	13%	XXX	XXX	XXX
Net Profit	$40.5M	$47.5M	XXX	XXX	XXX
Net Margin	6%	6%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Neurones Stock Performance

As of April 15, 2025, Neurones's stock price is EUR 45 (or $48).

Neurones has current market cap of EUR 1.1B (or $1.2B), and EV of EUR 871M (or $935M).

See Neurones trading valuation data

Neurones Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$935M	$1.2B	XXX	XXX	XXX	XXX	$2.40

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Neurones Valuation Multiples

As of April 15, 2025, Neurones has market cap of $1.2B and EV of $935M.

Neurones's trades at 1.1x LTM EV/Revenue multiple, and 8.8x LTM EBITDA.

Analysts estimate Neurones's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for Neurones and 10K+ public comps

Neurones Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	$935M	XXX	XXX	XXX
EV/Revenue	1.2x	XXX	XXX	XXX
EV/EBITDA	8.8x	XXX	XXX	XXX
P/E	22.1x	XXX	XXX	XXX
P/E/Growth	1.6x	XXX	XXX	XXX
EV/FCF	16.1x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Neurones Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Neurones Valuation Multiples

Neurones's NTM/LTM revenue growth is 6%

Neurones's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Neurones's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate Neurones's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for Neurones and other 10K+ public comps

Neurones Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	11%	XXX	XXX	XXX	XXX
EBITDA Margin	13%	XXX	XXX	XXX	XXX
EBITDA Growth	9%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	20%	XXX	XXX	XXX	XXX
Revenue per Employee	$0.1M	XXX	XXX	XXX	XXX
Opex per Employee	$0.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
Opex to Revenue	51%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry